Instrument Inactif

Autres langues MINDESTA OTC Bulletin Board

Actions

Recherche biotechnologique et médicale

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

29/05	CTT Pharmaceutical Holdings, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
15/04	CTT Pharmaceutical Holdings, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Autres langues

22/06	CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products
17/06	CTT Pharma Signs LOI with European Company
29/05	CTT Pharmaceutical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
14/05	CTT Pharma Signs LOI with European Company
15/04	CTT Pharmaceutical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
30/12	CTT Pharmaceutical Holdings, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025
30/12	CTT Pharmaceutical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
02/12	CTT Pharma CEO Issues Letter to Shareholders
20/11	CTT Pharma's CEO will issue a Letter to Shareholders
10/09/25	CTT Pharma Signs Contract for $3 Million Equity Line of Credit
10/06/25	CTT Pharma Grant Updates
12/03/25	CTT Pharma's CEO Issues Letter to Shareholders
22/01/25	CTT Pharma has engaged The OTC Markets to Uplist to The OTCQB
07/01/25	CTT Pharma and Johns Hopkins University Submits Proposal For $15 Million NIH Grant For Smoking Cessation
29/10/24	CTT Pharma's CEO Speaks at FDA and NIH Meeting for Advancing Smoking Cessation
21/08/24	CTT Pharmaceuticals Holdings, Inc. Successfully Completes 2 Year PCAOB Audit
05/08/24	Penny Stocks to Watch August 2024: SPZI, RJDG, HIRU, AABB more inside...
15/07/24	CTT Pharmaceuticals Holdings, Inc. Signs Contract for 2 year PCAOB Audit
25/06/24	CTT Pharma Gives Update on NSF Grant for Smoke Reduction Technology
27/03/24	CTT Pharma Partners with Johns Hopkins University for NIH Grant for a Smoking Cessation Product
28/03/23	CTT Pharma Appoints David Paton as Senior Advisor
30/01/23	CTT Pharma Corporate Updates
19/12/22	CTT Pharma Updates On Worldwide Patent Portfolio
06/12/22	CTT Pharma Receives Approval for European Patent
30/11/22	CTT Pharma Starts Product Development